MECHANISMS OF THE PATHOGENIC AUTOIMMUNE-RESPONSE IN LUPUS - PROSPECTS FOR SPECIFIC IMMUNOTHERAPY

被引:8
作者
DATTA, SK [1 ]
MOHAN, C [1 ]
DESAIMEHTA, A [1 ]
机构
[1] NORTHWESTERN UNIV, SCH MED, DEPT MICROBIOL IMMUNOL, CHICAGO, IL 60611 USA
关键词
SYSTEMIC LUPUS ERYTHEMATOSUS; ANTI-DNA AUTOANTIBODIES; AUTOIMMUNE T CELL RECEPTORS; CD40; CD40-LIGAND; IMMUNOTHERAPY;
D O I
10.1007/BF02918173
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A major step towards understanding the basic mechanism of systemic lupus erythematosus (SLE), the prototypic autoimmune disease that develops spontaneously, has been the identification of nucleosomes as a primary immunogen in this disease. The production of pathogenic autoantibodies in SLE results from an MHC class-II-restricted, cognate interaction between select populations of T helper cells and B cells that are specific for nucleosomal components. These observations pave the way for specific immunotherapy that blocks this pathogenic T and B cell interaction.
引用
收藏
页码:132 / 147
页数:16
相关论文
共 156 条
[1]   T-CELL RECEPTOR V-BETA GENES EXPRESSED BY IGG ANTI-DNA AUTOANTIBODY-INDUCING T-CELLS IN LUPUS NEPHRITIS - FORBIDDEN RECEPTORS AND DOUBLE-NEGATIVE T-CELLS [J].
ADAMS, S ;
ZORDAN, T ;
SAINIS, K ;
DATTA, SK .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (07) :1435-1443
[2]   JUNCTIONAL REGION SEQUENCES OF T-CELL RECEPTOR BETA-CHAIN GENES EXPRESSED BY PATHOGENIC ANTI-DNA AUTOANTIBODY-INDUCING HELPER T-CELLS FROM LUPUS MICE - POSSIBLE SELECTION BY CATIONIC AUTOANTIGENS [J].
ADAMS, S ;
LEBLANC, P ;
DATTA, SK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11271-11275
[3]  
ANDO DG, 1987, J IMMUNOL, V138, P3185
[4]   LACK OF RELATIONSHIP BETWEEN SERUM GP70 LEVELS AND THE SEVERITY OF SYSTEMIC LUPUS-ERYTHEMATOSUS IN MRL/1 MICE [J].
ANDREWS, J ;
HANG, L ;
THEOFILOPOULOS, AN ;
DIXON, FJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (02) :458-462
[5]   MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40 [J].
ARMITAGE, RJ ;
FANSLOW, WC ;
STROCKBINE, L ;
SATO, TA ;
CLIFFORD, KN ;
MACDUFF, BM ;
ANDERSON, DM ;
GIMPEL, SD ;
DAVISSMITH, T ;
MALISZEWSKI, CR ;
CLARK, EA ;
SMITH, CA ;
GRABSTEIN, KH ;
COSMAN, D ;
SPRIGGS, MK .
NATURE, 1992, 357 (6373) :80-82
[6]  
ATANASSOV C, 1991, CLIN EXP IMMUNOL, V86, P124
[7]  
ATKINSON MJ, 1985, J IMMUNOL, V135, P2524
[8]   THE CD40 ANTIGEN AND ITS LIGAND [J].
BANCHEREAU, J ;
BAZAN, F ;
BLANCHARD, D ;
BRIERE, F ;
GALIZZI, JP ;
VANKOOTEN, C ;
LIU, YJ ;
ROUSSET, F ;
SAELAND, S .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922
[9]  
BERNSTEIN KA, 1995, J IMMUNOL, V154, P2424
[10]   CELLULAR ONCOGENES AND RETROVIRUSES [J].
BISHOP, JM .
ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 :301-354